195 related articles for article (PubMed ID: 35355987)
1. T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C.
Flickinger JC; Singh J; Yarman Y; Carlson RD; Barton JR; Waldman SA; Snook AE
Front Immunol; 2022; 13():855759. PubMed ID: 35355987
[TBL] [Abstract][Full Text] [Related]
2. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.
Snook AE; Magee MS; Marszalowicz GP; Schulz S; Waldman SA
Cancer Immunol Immunother; 2012 May; 61(5):713-23. PubMed ID: 22057677
[TBL] [Abstract][Full Text] [Related]
3. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.
Witek M; Blomain ES; Magee MS; Xiang B; Waldman SA; Snook AE
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1188-95. PubMed ID: 24661671
[TBL] [Abstract][Full Text] [Related]
4. Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.
Snook AE; Baybutt TR; Xiang B; Abraham TS; Flickinger JC; Hyslop T; Zhan T; Kraft WK; Sato T; Waldman SA
J Immunother Cancer; 2019 Apr; 7(1):104. PubMed ID: 31010434
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope.
Snook AE; Baybutt TR; Hyslop T; Waldman SA
Hum Gene Ther Methods; 2016 Dec; 27(6):238-250. PubMed ID: 27903079
[TBL] [Abstract][Full Text] [Related]
6. Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.
Flickinger JC; Staudt RE; Singh J; Carlson RD; Barton JR; Baybutt TR; Rappaport JA; Zalewski A; Pattison A; Waldman SA; Snook AE
NPJ Vaccines; 2022 Jun; 7(1):61. PubMed ID: 35739202
[TBL] [Abstract][Full Text] [Related]
7. Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
Snook AE; Magee MS; Schulz S; Waldman SA
Eur J Immunol; 2014 Jul; 44(7):1956-66. PubMed ID: 24771148
[TBL] [Abstract][Full Text] [Related]
8. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
Sinnathamby G; Lauer P; Zerfass J; Hanson B; Karabudak A; Krakover J; Secord AA; Clay TM; Morse MA; Dubensky TW; Brockstedt DG; Philip R; Giedlin M
J Immunother; 2009 Oct; 32(8):856-69. PubMed ID: 19752748
[TBL] [Abstract][Full Text] [Related]
9. Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
Flickinger JC; Singh J; Carlson R; Leong E; Baybutt TR; Barton J; Caparosa E; Pattison A; Rappaport JA; Roh J; Zhan T; Bashir B; Waldman SA; Snook AE
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32819976
[TBL] [Abstract][Full Text] [Related]
10. Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.
Kim S; Zuiani A; Carrero JA; Hansen TH
Vaccine; 2012 Mar; 30(12):2178-86. PubMed ID: 22285270
[TBL] [Abstract][Full Text] [Related]
11. Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8
Xiang B; Baybutt TR; Berman-Booty L; Magee MS; Waldman SA; Alexeev VY; Snook AE
J Immunol; 2017 May; 198(9):3507-3514. PubMed ID: 28341670
[TBL] [Abstract][Full Text] [Related]
12. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer.
Singh R; Paterson Y
Cancer Res; 2006 Aug; 66(15):7748-57. PubMed ID: 16885378
[TBL] [Abstract][Full Text] [Related]
13. Development of a Listeria monocytogenes based vaccine against prostate cancer.
Shahabi V; Reyes-Reyes M; Wallecha A; Rivera S; Paterson Y; Maciag P
Cancer Immunol Immunother; 2008 Sep; 57(9):1301-13. PubMed ID: 18273616
[TBL] [Abstract][Full Text] [Related]
14. Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.
Singh R; Dominiecki ME; Jaffee EM; Paterson Y
J Immunol; 2005 Sep; 175(6):3663-73. PubMed ID: 16148111
[TBL] [Abstract][Full Text] [Related]
15. Structural Analyses of a Dominant Cryptosporidium parvum Epitope Presented by H-2K
Wang Y; Gao M; Li X; Zhu W; Zhao M; Li J; Liu X; Cao L; Li S; Zhang S; Zhang L; Fan S
mBio; 2023 Feb; 14(1):e0266622. PubMed ID: 36602309
[TBL] [Abstract][Full Text] [Related]
16. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
Xiong X; Jiao J; Gregory AE; Wang P; Bi Y; Wang X; Jiang Y; Wen B; Portnoy DA; Samuel JE; Chen C
J Infect Dis; 2017 May; 215(10):1580-1589. PubMed ID: 27703037
[TBL] [Abstract][Full Text] [Related]
17. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
18. Immunodominance of Adenovirus-Derived CD8
Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
[TBL] [Abstract][Full Text] [Related]
19. Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Chen Y; Yang D; Li S; Gao Y; Jiang R; Deng L; Frankel FR; Sun B
Oncogene; 2012 Apr; 31(17):2140-52. PubMed ID: 21927025
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.
Smith HA; Rekoske BT; McNeel DG
Vaccine; 2014 Mar; 32(15):1707-15. PubMed ID: 24492013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
